Canopy Growth CGC
NASDAQ CGC
$1.04 +0.00 (+0.00%)
At close: Aug 20, 2026 · 3:03 PM UTC

Canopy Growth (CGC) Other Non Operating Income (2019 - 2026)

Canopy Growth (CGC) posted Other Non Operating Income of -$29.7 million for Q4 2025, down 437.17% sequentially from $8.8 million in Q3 2025, and up 43.86% YoY from -$20.7 million in Q4 2024.

Canopy Growth (CGC) Other Non Operating Income (2019 - 2026) Analysis & Trends

Canopy Growth has reported Other Non Operating Income for 7 years, with the latest figure at -$29.7 million in Q4 2025.

  • Quarterly Other Non Operating Income rose 43.86% year-over-year to -$29.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$89.7 million (down 598.01% YoY) and the FY2026 annual result came in at -$1.1 million, up 99.59% from the prior year.
  • Other Non Operating Income slipped to -$29.7 million in Q4 2025 per CGC's latest filing, from $8.8 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $172.4 million in Q1 2024 and troughed at -$646.8 million in Q1 2022.
  • A 5-year average of -$52.0 million and a median of -$15.8 million in 2025 frame the typical range for Other Non Operating Income.
  • The sharpest annual moves came in 2022 and 2024: Other Non Operating Income plunged 141034.7% in 2022, then surged 8409.42% in 2024.
  • Over 5 years, Other Non Operating Income stood at $785402.7 in 2021, then plunged by 10932.89% to -$85.1 million in 2022, then tumbled by 38.05% to -$117.5 million in 2023, then jumped by 54.93% to -$52.9 million in 2024, then soared by 43.86% to -$29.7 million in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered -$29.7 million, $8.8 million, and -$15.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.86 Bn 42.90 Bn -
2 Teva Pharmaceutical Industries 43.19 Bn 39.54 Bn 2.15 Bn
3 Zoetis 31.46 Bn 29.79 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.57 Bn 22.77 Bn 5.10 Bn
5 United Therapeutics 22.15 Bn 19.49 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn
8 Elanco Animal Health 11.71 Bn 11.18 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn -
10 Canopy Growth 439.15 Mn 192.14 Mn 16.08 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 5.35 Mn
Dec 31, 2025 -29.72 Mn
Sep 30, 2025 8.81 Mn
Jun 30, 2025 -15.84 Mn
Dec 31, 2024 -52.93 Mn
Sep 30, 2024 -48.36 Mn
Jun 30, 2024 -53.10 Mn
Mar 31, 2024 172.40 Mn
Dec 31, 2023 -117.46 Mn
Sep 30, 2023 -89.30 Mn
Jun 30, 2023 -103,478.89
Mar 31, 2023 2.03 Mn
Dec 31, 2022 -85.08 Mn
Sep 30, 2022 -29.96 Mn
Jun 30, 2022 -3.87 Mn
Mar 31, 2022 -646.76 Mn
Dec 31, 2021 785,402.72
Sep 30, 2021 700,669.01
Jun 30, 2021 837,932.97
Mar 31, 2021 -458,257.49